Targeting Serine in Cancer: Is Two Better Than One?
Targeting Serine in Cancer: Is Two Better Than One?
复制标题
DOI:
10.1016/j.trecan.2021.06.004
复制
发表时间:
2021-08
期刊:
影响因子:
18.4
通讯作者:
Montrose DC
中科院分区:
文献类型:
--
作者:
Buqué A;Galluzzi L;Montrose DC
Several recent preclinical studies have demonstrated that simultaneously blocking exogenous and endogenous sources of serine in malignant cells mediates superior anticancer effects as compared with limiting either source alone. Here, we critically summarize key developments in targeting serine to treat cancer and discuss persisting challenges for implementing such a therapeutic approach in patients.
登录
查看更多内容
影响因子:
3.5
作者:
Rohde, Jason M.;Brimacombe, Kyle R.;Boxer, Matthew B.
通讯作者:
Boxer, Matthew B.
影响因子:
16.6
作者:
Tajan M;Hennequart M;Cheung EC;Zani F;Hock AK;Legrave N;Maddocks ODK;Ridgway RA;Athineos D;Suárez-Bonnet A;Ludwig RL;Novellasdemunt L;Angelis N;Li VSW;Vlachogiannis G;Valeri N;Mainolfi N;Suri V;Friedman A;Manfredi M;Blyth K;Sansom OJ;Vousden KH
通讯作者:
Vousden KH
影响因子:
64.8
作者:
Maddocks OD;Berkers CR;Mason SM;Zheng L;Blyth K;Gottlieb E;Vousden KH
通讯作者:
Vousden KH
影响因子:
20.8
作者:
Mendez-Lucas, Andres;Lin, Wei;Yuneva, Mariia
通讯作者:
Yuneva, Mariia
影响因子:
28.2
作者:
Ngo, Bryan;Kim, Eugenie;Pacold, Michael E.
通讯作者:
Pacold, Michael E.